Fate Therapeutics (FATE) PT Raised to $25 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Edward Tenthoff raised the price target on Fate Therapeutics (NASDAQ: FATE) to $25.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
